Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
LONDON (Alliance News) - GlaxoSmithKline PLC Monday announced a series of new investments in sub-Saharan Africa of up to GBP130 million over the next five years to increase access to medicines, build its capacity and contribute to its long-term business growth. Glaxo said it plans to build
31 Mar 14 10:00* Up to 100 mln pounds for new drug manufacturing in Africa * GSK looks at Rwanda, Ghana and Ethiopia for new factories * Further investment in drug R&D focused on continent By Ben Hirschler March 31 (Reuters) - Drugmaker GlaxoSmithKline plans to invest up to 130 million p
31 Mar 14 10:00- Busy week for economic data - German retail sales rise, Eurozone CPI ahead - Insurance stocks rebound after heavy falls techMARK 2,778.57 +0.59% FTSE 100 6,657.68 +0.64% FTSE 250 16,276.97 +0.59% UK stocks were trading at a three-week high on Monday morning as investors began the week in a bulli
31 Mar 14 08:29LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its Phase III STABILITY study for darapladib in the treatment of patients with chronic coronary heart disease failed to meet its primary endpoint, although it said that the effects of the drug on the reduction of coronary events was of
31 Mar 14 07:43LONDON (Alliance News) - Shares have opened higher Monday ahead of a week with a full calendar of economic data reports scheduled.<br /><br /><strong>Rolls-Royce</strong> Holdings PLC said it has won a deal worth more than USD50 million to support the US Marines Corps' fleet of KC-130J air-to-
31 Mar 14 07:38GlaxoSmithKline (GSK) said the third phase of its study of darpladib failed to meet its target for the prevention of stroke. The trial randomised 15,828 patients with chronic coronary heart disease to receive 160mg of darapladib or placebo once daily. No difference was witnessed in the treatment g
31 Mar 14 07:32(Adds independent doctor comment) By Bill Berkrot and Ransdell Pierson WASHINGTON, March 30 (Reuters) - A new type of heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated heart disease, showed signs of
30 Mar 14 20:59Big insurance companies want Martin Wheatley, Chief Executive of the Financial Conduct Authority, to resign after the watchdog sent their shares into freefall by making a misleading announcement about an industry probe, the Sunday Times said. The Association of British Insurers is expected to write
30 Mar 14 16:53(Adds study details, researcher, Glaxo comment, background) By Bill Berkrot and Ransdell Pierson WASHINGTON, March 30 (Reuters) - A new type of heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated hear
30 Mar 14 15:32LONDON, March 30 (Reuters) - GlaxoSmithKline plans to make new investments in additional factories and drug research in Africa, its chief executive said on Sunday, as the pharmaceuticals group broadens its bet on promising emerging markets. Andrew Witty said the continent was important for
30 Mar 14 13:51WASHINGTON, March 30 (Reuters) - An experimental heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated heart disease, showed signs of potential benefit, the trial's co-leader said Sunday. The results presente
30 Mar 14 12:56LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that it had acquired full ownership of its Indonesian Consumer Healthcare business for IDR465 billion, equivalent to GBP24.6 million, and sold its non-core brand and manufacturing facility in the country. The company bought the remain
28 Mar 14 13:49LONDON, March 28 (Reuters) - GlaxoSmithKline is betting more on Indonesia by taking full control of its consumer healthcare unit in the country, underscoring a drive by the drugmaker to build up its presence in fast-growing emerging markets. The move, announced on Friday, mirrors the Britis
28 Mar 14 13:43By Freya Berry LONDON, March 28 (Reuters) - Buyout firms are finding it harder to take part in mergers and acquisitions as the lure of stronger equity markets persuades more funds seeking to exit assets to try their luck with a public share sale or turn to cash-rich corporate buyers.
28 Mar 14 00:00* NICE to look at "wider societal impact" of new drugs * Move may mean more positive recommendations in future * NICE CEO says firms must offer NHS "very best price" * Cancer campaigners fear less money for end-of-life care (Adds further reaction from cancer charity) By
27 Mar 14 17:48
Last checked at